Literature DB >> 10614837

High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity.

A Matsumori1, H Igata, K Ono, A Iwasaki, T Miyamoto, R Nishio, S Sasayama.   

Abstract

Results of recent studies suggest that proinflammatory cytokines cause myocardial contractile dysfunction, and that the drugs used to treat heart failure modulate the production of cytokines. This study was designed to examine the effects of digoxin in a murine model of heart failure induced by viral myocarditis. Four-week-old inbred DBA/2 mice were inoculated intraperitoneally with encephalomyocarditis virus (EMCV). Digoxin was given orally in doses of 0.1, 1 or 10 mg/kg daily from the day of virus inoculation. Interleukin (IL)-1beta, IL-6 and tumor necrosis factor (TNF)-alpha production in the heart were measured on day 5 after EMCV inoculation by enzyme-linked immunosorbent assay. The 14-day mortality tended to be increased in mice treated with 1 mg/kg, and was significantly increased in the group treated with 10 mg/kg per day. Myocardial necrosis and cellular infiltration on day 6 were significantly more severe in the high-dose digoxin group than in the control group. In the animals treated with 1 mg/kg digoxin, IL-1beta was significantly higher than in the control group. Intracardiac TNF-alpha levels were increased in a dose-dependent manner. These results suggest that digoxin worsens viral myocarditis, and that its use in high doses should be avoided in patients suffering from heart failure due to viral myocarditis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614837     DOI: 10.1253/jcj.63.934

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  16 in total

Review 1.  [Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery].

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Herz       Date:  2010-03       Impact factor: 1.443

Review 2.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

Review 3.  The role of inflammatory mediators in the failing heart: immunomodulation of cytokines in experimental models of heart failure.

Authors:  A Matsumori; S Sasayama
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

4.  Therapy for pediatric myocarditis.

Authors:  Charles E Canter
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

5.  Myocarditis in infants and children: A review for the paediatrician.

Authors:  A B Dancea
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

Review 6.  An approach to the treatment of pediatric myocarditis.

Authors:  Daniel Levi; Juan Alejos
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Acute myocarditis in children: current concepts and management.

Authors:  Sudhir Vashist; Gautam K Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-10

Review 8.  Myocarditis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

9.  Diagnosis and management of viral myocarditis.

Authors:  William H Frishman; Joshua Zeidner; Nauman Naseer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

10.  The effect of high dose digoxin on cytokines in healthy dogs.

Authors:  Haluk Dülger; Mehmet Ramazan Sekeroğlu; Beyhan Eryonucu; Tevfik Noyan; Süleyman Alici
Journal:  Mediators Inflamm       Date:  2002-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.